Po-ku Chen
Taitung, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
The presence of anti-Ro52/SSA antibodies may predict concomitant pulmonary hypertension and poorer survival in patients with connective tissue disease-associated interstitial lung disease.
Journal: Clinical rheumatology
Published: February 05, 2026
A panel incorporating genetic variants of RIN3, NLRC3, and SLX4 shows promise in predicting remission after tofacitinib therapy in rheumatoid arthritis patients.
Journal: Clinical and experimental rheumatology
Published: May 19, 2025
Toward a personalized therapy of still's disease based on immunologic endotypes: a narrative review.
Toward a personalized therapy of still's disease based on immunologic endotypes: a narrative review.
Journal: Expert review of clinical immunology
Published: February 10, 2025
Anti-peptide antibodies, anti-SNRK and anti-HUWE1 antibodies as potential predictors of good response to tofacitinib therapy in rheumatoid arthritis patients.
Journal: Rheumatology (Oxford, England)
Published: September 06, 2024
Elevated remnant cholesterol as a potential predictor for cardiovascular events in rheumatoid arthritis patients.
Journal: Frontiers in cardiovascular medicine
Published: June 14, 2024
Prior herpes zoster occurrence and high-dose corticosteroids increase herpes zoster risk in rheumatoid arthritis patients receiving janus kinase inhibitors in a retrospective and observational study.
Journal: Clinical rheumatology
Published: April 09, 2024
Association of the Reduced Levels of Monocyte Chemoattractant Protein-1 with Herpes Zoster in Rheumatoid Arthritis Patients Treated with Janus Kinase Inhibitors in a Single-Center Cohort.
Journal: Microorganisms
Published: March 27, 2024
Increased NAFLD risk in newly diagnosed patients with RA during the first 4 years of follow-up: a nationwide, population-based cohort study.
Journal: BMJ open
Published: January 25, 2024
The NLRP3 Inflammasome as a Pathogenic Player Showing Therapeutic Potential in Rheumatoid Arthritis and Its Comorbidities: A Narrative Review.
Journal: International journal of molecular sciences
Published: December 06, 2023
Significant association of elevated serum galectin-9 levels with the development of non-alcoholic fatty liver disease in patients with rheumatoid arthritis.
Journal: Frontiers in medicine
Published: November 30, 2023
The Sizes and Composition of HDL-Cholesterol Are Significantly Associated with Inflammation in Rheumatoid Arthritis Patients.
Journal: International journal of molecular sciences
Published: May 30, 2023
Last Updated: 09/26/2026